Perfromance Wealth Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,726
| Closed | -$210K | – | 186 |
|
|
2024
Q4 | $210K | Sell |
1,726
-1,200
| -41% | -$146K | 0.01% | 173 |
|
|
2024
Q3 | $365K | Sell |
2,926
-1,074
| -27% | -$134K | 0.01% | 125 |
|
|
2024
Q2 | $632K | Buy |
4,000
+1,500
| +60% | +$237K | 0.02% | 74 |
|
|
2024
Q1 | $324K | Buy |
+2,500
| New | +$324K | 0.01% | 122 |
|
|
2023
Q4 | – | Sell |
-2,700
| Closed | -$327K | – | 178 |
|
|
2023
Q3 | $327K | Buy |
2,700
+500
| +23% | +$60.6K | 0.02% | 131 |
|
|
2023
Q2 | $246K | Hold |
2,200
| – | – | 0.01% | 159 |
|
|
2023
Q1 | $303K | Buy |
2,200
+600
| +38% | +$82.7K | 0.02% | 141 |
|
|
2022
Q4 | $207K | Buy |
+1,600
| New | +$207K | 0.01% | 157 |
|